Establishment and Validation of a Prognostic Immune Signature in Neuroblastoma.
Yunhu YuYu ZengXiangping XiaJian-Guo ZhouFang CaoPublished in: Cancer control : journal of the Moffitt Cancer Center (2022)
Herein, we presented an immune landscape with IPGPN for prognosis prediction in neuroblastoma, which complements the present understanding of the immune signature in neuroblastoma.
Keyphrases